Wednesday, July 22, 2026
BusinessEXCLUSIVE

AC Health Aims for Growth Through Hospital Acquisitions

The healthcare provider plans to expand its network with multiple acquisitions this year.

MD

Mateo Dela Cruz

July 13, 20264 min read18 views
AC Health Aims for Growth Through Hospital Acquisitions
AC Health is expanding its healthcare network with strategic acquisitions and new clinics.
Share:

Ayala Healthcare Holdings, Inc. (AC Health) is actively pursuing the acquisition of hospitals as part of its growth strategy. The company aims to make at least one acquisition announcement within the year.

Chief Strategy and Investment Officer Rafael Jaime V. Recio confirmed that the focus will initially be on acquiring existing facilities rather than establishing new ones from scratch.

Strategic Acquisition Targets

We have a few acquisition targets in the pipeline. Hopefully, we’ll be able to announce something within the year.

Rafael Jaime V. Recio, Chief Strategy and Investment Officer

The company is particularly interested in hospitals with a minimum of 100 beds and located in urban areas. Recio emphasized the importance of the quality of existing facilities and a stable medical staff.

  • Targeting hospitals with at least 100 beds
  • Prioritizing Level 2 classified facilities in urban centers

In addition to its acquisition plans, AC Health intends to open three to five new clinics annually over the next three to five years.

The company has successfully expanded its multi-specialty outpatient network, recently launching a flagship center in Makati City. Plans are underway to further increase its presence in Batangas and Taguig.

AC Health’s growth strategy aims to expand its network to 1,150 retail pharmacies, 300 clinics, and 10 hospitals through a combination of acquisitions and organic growth.

In a strategic partnership with Japan's Taisho Pharmaceuticals, AC Health Pharma will distribute healthcare products across its facilities. Recio remains optimistic about the company's trajectory despite the challenges faced by the industry.

It looks like we’re on track. It’s been an encouraging 2026 so far, despite all the challenges we’ve seen lately.

Rafael Jaime V. Recio, Chief Strategy and Investment Officer